Researchers Developed a Novel Tool for Proteome-Wide Identification of Small-Molecule Degrader Targets
www.marinbio.com/researchers-...
#PROTAC #TargetedProteinDegradation #LYTAC #MolecularGlues #GlueTAC #bioPROTAC #AUTAC. #AbTAC #Cancertherapy #Immunotherapy #drugdiscovery
www.marinbio.com/researchers-...
#PROTAC #TargetedProteinDegradation #LYTAC #MolecularGlues #GlueTAC #bioPROTAC #AUTAC. #AbTAC #Cancertherapy #Immunotherapy #drugdiscovery
Researchers Developed a Novel Tool for Proteome-Wide Identification of Small-Molecule Degrader Targets - Marin Biologic Laboratories
Researchers from the German Cancer Research Center (DKFZ), CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, and Heidelberg University Medical Faculty have developed an ...
www.marinbio.com
November 24, 2024 at 7:16 AM
Everybody can reply
1 likes
Targeted Protein Degradation/PROTAC for Innovative Drug Development: Current Trends and Future Prospects.
www.marinbio.com/protacs-inno...
#PROTAC #TargetedProteinDegradation #LYTAC #MolecularGlues #GlueTAC #bioPROTAC #AUTAC. #AbTAC #Cancertherapy #Immunotherapy #drugdiscovery
www.marinbio.com/protacs-inno...
#PROTAC #TargetedProteinDegradation #LYTAC #MolecularGlues #GlueTAC #bioPROTAC #AUTAC. #AbTAC #Cancertherapy #Immunotherapy #drugdiscovery
PROTACs: Future Trends and Innovative Drug Development
Explore the latest trends in PROTAC drug development and its impact on targeted protein degradation therapies. Learn about current research and future prospects.
www.marinbio.com
November 15, 2024 at 4:32 PM
Everybody can reply
2 reposts
5 likes
This is a very interesting financing for those who follow #MolecularGlues #TPD #TargetedProteinDegradation round by #BioTheryX. @jaybradner @HartungIngo @MilkaKostic @elkingtonxy @ChemGenetics @CrisMayorRuiz @CraigMCrews
November 19, 2024 at 2:05 PM
Everybody can reply
Proteolysis-Targeting Vaccines (PROTAVs): A Novel Approach in Cancer Immunotherapy
www.marinbio.com/proteolysis-...
#PROTAC #TargetedProteinDegradation #LYTAC #MolecularGlues #GlueTAC #bioPROTAC #AUTAC #AbTAC #Cancertherapy #Immunotherapy #drugdiscovery
www.marinbio.com/proteolysis-...
#PROTAC #TargetedProteinDegradation #LYTAC #MolecularGlues #GlueTAC #bioPROTAC #AUTAC #AbTAC #Cancertherapy #Immunotherapy #drugdiscovery
Proteolysis-Targeting Vaccines (PROTAVs): A Novel Approach in Cancer Immunotherapy - Marin Biologic Laboratories
From PROTACs to PROTAVs: A New Era in Cancer Vaccine Development Cancer immunotherapy, particularly immune checkpoint blockade (ICB), has transformed the treatment of advanced cancers, notably melanom...
www.marinbio.com
November 15, 2024 at 4:40 PM
Everybody can reply
1 likes
🤝 #MeetOurScientists: Dr. Cristina Mayor-Ruiz, from #IRBBarcelona
🎯🔬 Learn how Dr. Mayor-Ruiz's pioneering work in #TargetedProteinDegradation is unlocking new ways to treat untouchable diseases.
📽️ youtu.be/d8ig0j7fQMM?feature=shared
#Chembio #ProteinDegradation #TPD #IRBScience
🧪
🎯🔬 Learn how Dr. Mayor-Ruiz's pioneering work in #TargetedProteinDegradation is unlocking new ways to treat untouchable diseases.
📽️ youtu.be/d8ig0j7fQMM?feature=shared
#Chembio #ProteinDegradation #TPD #IRBScience
🧪
Meet our Scientists - Dr. Cristina Mayor-Ruiz: Advancing Drug Discovery with Protein Degradation
YouTube video by IRB Barcelona
youtu.be
November 28, 2024 at 4:28 PM
Everybody can reply
3 reposts
12 likes
🤝 #MeetOurScientists: Dr. @crismayorruiz.bsky.social.
🎯🔬 Learn how Dr. Mayor-Ruiz's pioneering work in #TargetedProteinDegradation is unlocking new ways to treat untouchable diseases.
📽️ https://s.mtrbio.com/higqmhbfzt
#IRBScience #ProteinDegradation #TPD
🧪
🎯🔬 Learn how Dr. Mayor-Ruiz's pioneering work in #TargetedProteinDegradation is unlocking new ways to treat untouchable diseases.
📽️ https://s.mtrbio.com/higqmhbfzt
#IRBScience #ProteinDegradation #TPD
🧪
Enjoy the videos and music that you love, upload original content and share it all with friends, family and the world on YouTube.
s.mtrbio.com
January 24, 2025 at 10:02 AM
Everybody can reply
2 reposts
9 likes
A great day at the University of Pavia presenting on new directions in #targetedproteindegradation. Vibrant environment and discussions with colleagues and friends @kajastelab.bsky.social
Thanks @fmagnani.bsky.social for the warm welcome and the opportunity to connect with this scientific community
Thanks @fmagnani.bsky.social for the warm welcome and the opportunity to connect with this scientific community
May 8, 2025 at 4:59 AM
Everybody can reply
1 reposts
9 likes
📝 Online now - the Review "E3 ubiquitin ligases in signaling, disease, and therapeutics" from Shaun Olsen et al.
#ubiquitin #E3UbiquitinLigase #UbiquitinProteasomeSystem #TargetedProteinDegradation
Read it here 👉 authors.elsevier.com/sd/article/S...
#ubiquitin #E3UbiquitinLigase #UbiquitinProteasomeSystem #TargetedProteinDegradation
Read it here 👉 authors.elsevier.com/sd/article/S...
September 22, 2025 at 2:21 PM
Everybody can reply
3 reposts
1 quotes
4 likes
2 saves
VHL ligands engage the VHL E3 ligase, a highly validated recruiter in PROTAC design, offering robust degradation profiles. Their structural diversity supports fine-tuning of ternary complex stability and pharmacological properties.
fluorochem.co.uk/product-cate...
🧪 #TargetedProteinDegradation
fluorochem.co.uk/product-cate...
🧪 #TargetedProteinDegradation
October 2, 2025 at 11:13 AM
Everybody can reply
AI Breakthrough By UW Scientists Targets ‘Undruggable’ Proteins, Paving Path to Novel Therapies.
#UndruggableNoMore, #AIDrugDiscovery, #PROTAC, #TargetedProteinDegradation, #UWMedicine, #CancerTherapy, #AlzheimersResearch, #MedicalBreakthrough,
medium.com/@jckapadia00...
#UndruggableNoMore, #AIDrugDiscovery, #PROTAC, #TargetedProteinDegradation, #UWMedicine, #CancerTherapy, #AlzheimersResearch, #MedicalBreakthrough,
medium.com/@jckapadia00...
AI Breakthrough By UW Scientists Targets ‘Undruggable’ Proteins, Paving Path to Novel Therapies
For decades, a significant portion of human biology — estimated at around 85% of all proteins — has remained frustratingly out of reach…
medium.com
July 24, 2025 at 4:47 AM
Everybody can reply
Potential therapeutic target in acute myeloid leukemia (AML): Geng et al. explore the development of molecular glue degraders (MGDs) targeting casein kinase 1 alpha (CK1α), a potential therapeutic target in AML.
Learn more: bit.ly/3OFLfBo
#TargetedProteinDegradation #proteomics #massspectrometry
Learn more: bit.ly/3OFLfBo
#TargetedProteinDegradation #proteomics #massspectrometry
Preprint: Development of potent and selective CK1α Molecular Glue Degraders - IonOpticks
This molecular glue degraders study by Geng et al. was conducted utilising a 25cm IonOpticks Aurora Ultimate UHPLC column.
bit.ly
December 4, 2024 at 3:49 AM
Everybody can reply
1 reposts
4 likes
Online now - the Review "Routes to #MolecularGlueDegrader discovery" from Yanfen Liu, Yong Cang, and colleagues.
#MGD #TargetedProteinDegradation #TPD #PROTAC #HighThroughputScreening
authors.elsevier.com/a/1kN5M3S6Gf...
#MGD #TargetedProteinDegradation #TPD #PROTAC #HighThroughputScreening
authors.elsevier.com/a/1kN5M3S6Gf...
January 3, 2025 at 4:31 PM
Everybody can reply
2 likes
Induced Proximity Strategies: Bridging Molecules for Advanced Immunotherapy
www.marinbio.com/antibody-rec...
#immunotherapy #protac #targetedproteindegradation #tpd #molecularglue #cancer #antibody #macrophages
www.marinbio.com/antibody-rec...
#immunotherapy #protac #targetedproteindegradation #tpd #molecularglue #cancer #antibody #macrophages
Antibody Recruiting Molecules (ARMs) and Covalent Immune Recruiters (CIRs): Next-Generation Bifunctional Molecules Transforming Immunotherapy - Marin Biologic Laboratories
The concept of "induced proximity" in cell-cell interactions is an emerging strategy in immunotherapy, where molecules bring immune cells and target cells into close contact, facilitating immune-media...
www.marinbio.com
November 17, 2024 at 1:01 AM
Everybody can reply
1 likes
🚨🚨 Preprint from @craigcrews could be transformative for #TargetedProteinDegradation. @sandymacrae23, @SangamoTx's #ZFN transcription modulation is PERFECT for this. $SGMO
👉🌞👉 "laborious small molecule ligand discovery campaigns are not required"
@jaybradner @ChemGenetics
👉🌞👉 "laborious small molecule ligand discovery campaigns are not required"
@jaybradner @ChemGenetics
November 19, 2024 at 2:11 PM
Everybody can reply